The charity Breast Cancer Now has awarded £90,000 to Dr James Boyne from the University of Bradford so he can lead the three-year mission.
Scientists estimate that there’s a 20% larger danger of creating breast cancer in individuals with type 2 diabetes, though researchers have been unable to decide precisely why each situations are linked.
Breast cancer is presently the most typical cancer in girls and round 48,000 girls are identified yearly. One principle behind the connection between breast cancer and type 2 diabetes is that elements within the blood that trigger clotting, referred to as platelets, could also be accountable.
Dr Boyne, a lecturer in molecular and mobile biology on the college, plans to have a look at how the fragments of platelets bind to breast cancer cells, in a bid to perceive the connection between the situations.
“We are hopeful that we will be able to identify new mechanisms that drive breast cancer progression in type two diabetics to ensure the best possible outcomes for these patients,” mentioned Prof Boyne.
Dr Richard Berks, senior analysis communications officer at Breast Cancer Now, mentioned: “Understanding the link between these two diseases may help doctors to predict whether a diabetic patient is likely to develop metastatic breast cancer, so that effective treatments can be put in place to reduce the risk of the disease spreading and becoming incurable.”
Dr Berks mentioned the findings may lead to “the development of new, highly-specific therapies for those with secondary breast cancer”.
He added: “Our ambition is that by 2050, everyone who develops breast cancer will live. Dr Boyne’s project could help bring us one step closer to this goal.”
